Legionella: Virulence factors and host response

Current Opinion in Infectious Diseases

Volumn 29, Issue 3, 2016, Pages 280-286

  Misch, Elizabeth Ann ^a,b  

^a Boise VA Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

antibody subclasses; innate immune response; Legionella; virulence

Indexed keywords

ANTIBODY; CASPASE 11; CASPASE 3; CASPASE 4; INTERLEUKIN 1BETA CONVERTING ENZYME; IRON; RAB PROTEIN; VIRULENCE FACTOR; BACTERIUM ANTIBODY; CASPASE;

ACIDIFICATION; APOPTOSIS; BACTERIAL GROWTH; CELL VACUOLE; COMMUNITY ACQUIRED PNEUMONIA; ENDOPLASMIC RETICULUM STRESS; HOST CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEGIONELLA PNEUMOPHILA; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PHAGOSOME; PROTEIN SYNTHESIS; REVIEW; UNFOLDED PROTEIN RESPONSE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LEGIONNAIRE DISEASE; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY;

ANTIBODIES, BACTERIAL; CASPASES; HOST-PATHOGEN INTERACTIONS; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; VIRULENCE FACTORS;

EID: 84961393357     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000268     Document Type: Review

References (74)

1. Fang GD, Yu VL, Vickers RM. Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemio-logical review. Medicine (Baltimore) 1989; 68:116-132.
2. Phin N, Parry-Ford F, Harrison T, et al. Epidemiology and clinical management of Legionnaires' disease. Lancet Infect Dis 2014; 14:1011-1021.
3. Neil K, Berkelman R. Increasing incidence of Legionellosis in the United States, 1990-2005: changing epidemiologic trends. Clin Infect Dis 2008; 47:591-599.
4. Sabria M, Yu VL. Hospital-acquired Legionellosis: solutions for a preventable infection. Lancet Infect Dis 2002; 2:368-373.
5. Horwitz MA. Phagocytosis of the legionnaires' disease bacterium (legionella pneumophila) occurs by a novel mechanism: engulfment within a Pseudopod coil. Cell 1984; 36:27-33.
6. Isberg RR, O'Connor TJ, Heidtman M. The Legionella pneumophila replication vacuole: making a cosy niche inside host cells. Nat Rev Microbiol 2009; 7:13-24.
7. Kagan JC, Roy CR. Legionella phagosomes intercept vesicular traffic from endoplasmic reticulum exit sites. Nat Cell Biol 2002; 4:945-954.
8. Hubber A, Roy CR. Modulation of host cell function by Legionella pneumophila type IV effectors. Annu Rev Cell Dev Biol 2010; 26:261-283.
9. Rolando M, Buchrieser C. Legionella pneumophila type IV effectors hijack the transcription and translation machinery of the host cell. Trends Cell Biol 2014; 24:771-778.
10. Horwitz MA. Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes. J Exp Med 1983; 158:1319-1331.
11. Horwitz MA. The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med 1983; 158:2108-2126.
12. Vogel JP, Isberg RR. Cell biology of Legionella pneumophila. Curr Opin Microbiol 1999; 2:30-34.
13. Marra A, Blander SJ, Horwitz MA, Shuman HA. Identification of a Legionella pneumophila locus required for intracellular multiplication in human macro-phages. Proc Natl Acad Sci USA 1992; 89:9607-9611.
14. Fontana MF, Vance RE. Two signal models in innate immunity. Immunol Rev 2011; 243:26-39.
15. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410:1099-1103.
16. Hawn TR, Verbon A, Lettinga KD, et al. Acommon dominant TLR5stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 2003; 198:1563-1572.
17. Akamine M, Higa F, Arakaki N, et al. Differential roles of Toll-like receptors 2 and 4 in in vitro responses of macrophages to Legionella pneumophila. Infect Immun 2005; 73:352-361.
18. Hawn TR, Smith KD, Aderem A, Skerrett SJ. Myeloid differentiation primary response gene (88)-and toll-like receptor 2-deficient mice are susceptible to infection with aerosolized Legionella pneumophila. J Infect Dis 2006; 193:1693-1702.
19. Girard R, Pedron T, Uematsu S, et al. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J Cell Sci 2003; 116:293-302.
20. Bhan U, Trujillo G, Lyn-Kew K, et al. Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila. Infect Immun 2008; 76:2895-2904.
21. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-384.
22. Gurung P, Malireddi RK, Anand PK, et al. Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-beta (TRIF)-mediated cas-pase-11 protease production integrates Toll-like receptor 4 (TLR4) protein-and Nlrp3 inflammasome-mediated host defense against enteropathogens. J Biol Chem 2012; 287:34474-34483.
23. Rathinam Vijay AK, Vanaja Sivapriya K, Waggoner L, et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 2012; 150:606-619.
24. Ge J, Gong Y-N, Xu Y, Shao F. Preventing bacterial DNA release and absent in melanoma 2 inflammasome activation by a Legionella effector functioning in membrane trafficking. Proc Natl Acad Sci USA 2012; 109: 6193-6198.
25. Lightfield KL, Persson J, Trinidad NJ, et al. Differential requirements for NAIP5 in activation of the NLRC4 inflammasome. Infect Immun 2011; 79:1606-1614.
26. Miao EA, Alpuche-Aranda CM, Dors M, et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1b via Ipaf. Nat Immunol 2006; 7:569-575.
27. Lightfield KL, Persson J, Brubaker SW, et al. Critical role of Naip5 in inflammasome activation by a conserved C-terminal domain of flagellin. Nature Immunol 2008; 9:1171-1178.
28. Molofsky AB, Byrne BG, Whitfield NN, et al. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J Exp Med 2006; 203:1093-1104.
29. Miao EA, Leaf IA, Treuting PM, et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 2010; 11:1136-1142.
30. Aachoui Y, Leaf IA, Hagar JA, et al. Caspase-11 protects against bacteria that escape the vacuole. Science 2013; 339:975-978.
31. Kayagaki N, Warming S, Lamkanfi M, et al. Noncanonical inflammasome activation targets caspase-11. Nature 2011; 479:117-121.
32. Cerqueira DM, Pereira MSF, Silva ALN, et al. Caspase-1 but not caspase-11 is required for NLRC4-mediated pyroptosis and restriction of infection by flagellated Legionella species in mouse macrophages and in vivo. J Immunol 2015; 195:2303-2311.
33. Case CL, Kohler LJ, Lima JB, et al. Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila. Proc Natl Acad Sci USA 2013; 110:1851-1856.
34. Casson CN, Copenhaver AM, Zwack EE, et al. Caspase-11 activation in response to bacterial secretion systems that access the host cytosol. PLoS Pathog 2013; 9:e1003400.
35. Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell 2014; 157:1013-1022.
36. Broz P, Ruby T, Belhocine K, et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 2012; 490:288-291.
37. Akhter A, Caution K, Abu Khweek A, et al. Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization. Immunity 2012; 37:35-47.
38. Hagar JA, Powell DA, Aachoui Y, et al. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 2013; 341:1250-1253.
39. Kayagaki N, Wong MT, Stowe IB, et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013; 341:1246-1249.
40. Shi J, Zhao Y, Wang Y, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 2014; 514:187-192.
41. Wang S, Miura M, Jung YK, et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92:501-509.
42. Kamada S, Funahashi Y, Tsujimoto Y. Caspase-4 and caspase-5, members of the ICE/CED-3 family of cysteine proteases, are CrmA-inhibitable proteases. Cell Death Differ 1997; 4:473-478.
43. Casson CN, Yu J, Reyes VM, et al. Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens. Proc Natl Acad Sci USA 2015; 112:6688-6693.
44. Derre I, Isberg RR. Legionella pneumophila replication vacuole formation involves rapid recruitment of proteins of the early secretory system. Infect Immun 2004; 72:3048-3053.
45. Kagan JC, Stein MP, Pypaert M, Roy CR. Legionella subvert the functions of Rab1 and Sec22b to create a replicative organelle. J Exp Med 2004; 199:1201-1211.
46. Hardiman CA, Roy CR. AMPylation is critical for Rab1 localization to vacuoles containing Legionella pneumophila. MBio 2014; 5:e01035-e1113.
47. Connor MG, Pulsifer AR, Price CT, et al. Yersinia pestis requires host Rab1b for survival in macrophages. PLoS Pathog 2015; 11:e1005241.
48. Cianciotto NP.An update on iron acquisition byLegionella pneumophila: new pathways for siderophore uptake and ferric iron reduction. Future Microbiol 2015; 10:841-851.
49. Hood MI, Skaar EP. Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol 2012; 10:525-537.
50. Philpott CC, Ryu MS. Special delivery: distributing iron in the cytosol of mammalian cells. Front Pharmacol 2014; 5:173.
51. Isaac DT, Laguna RK, Valtz N, Isberg RR. MavN is a Legionella pneumophila vacuole-associated protein required for efficient iron acquisition during intracellular growth. Proc Natl Acad Sci USA 2015; 112:E5208-E5217.
52. Portier E, Zheng H, Sahr T, et al. IroT/mavN, a new iron-regulated gene involved in Legionella pneumophila virulence against amoebae and macro-phages. Environ Microbiol 2015; 17:1338-1350.
53. Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008; 454:455-462.
54. Lee SY, Lee MS, Cherla RP, Tesh VL. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cell Microbiol 2008; 10:770-780.
55. Treacy-Abarca S, Mukherjee S. Legionella suppresses the host unfolded protein response via multiple mechanisms. Nat Commun 2015; 6:7887.
56. Hempstead AD, Isberg RR. Inhibition of host cell translation elongation by Legionella pneumophila blocks the host cell unfolded protein response. Proc Natl Acad Sci USA 2015; 112:E6790-E6797.
57. Hasnain SZ, Lourie R, Das I, et al. The interplay between endoplasmic reticulum stress and inflammation. Immunol Cell Biol 2012; 90:260-270.
58. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511.
59. Fontana MF, Banga S, Barry KC, et al. Secreted bacterial effectors that inhibit host protein synthesis are critical for induction of the innate immune response to virulent Legionella pneumophila. PLoS Pathog 2011; 7:e1001289.
60. Barry KC, Fontana MF, Portman JL, et al. IL-1 signaling initiates the inflammatory response to virulent Legionella pneumophila in vivo. J Immunol 2013; 190:6329-6339.
61. Shin S, Case CL, Archer KA, et al. Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophila. PLoS Pathog 2008; 4:e1000220.
62. Vance RE, Hawn TR. Chapter 5: The genetics and immunology of host resistance to Legionella infection. In: Heuner K, Swanson MS, editors. Legionella: Molecular Microbiology. University of Wü rzburg, Germany, and University of Michigan, USA: Caister Academic Press; 2008.
63. Fontana MF, Shin S, Vance RE. Activation of host mitogen-activated protein kinases by secreted Legionella pneumophila effectors that inhibit host protein translation. Infect Immun 2012; 80:3570-3575.
64. Losick VP, Isberg RR. NF-B translocation prevents host cell death after low-dose challenge by Legionella pneumophila. J Exp Med 2006; 203:2177-2189.
65. Asrat S, Dugan AS, Isberg RR. The frustrated host response to Legionella pneumophila is bypassed by MyD88-dependent translation of pro-inflammatory cytokines. PLoS Pathog 2014; 10:e1004229.
66. Copenhaver AM, Casson CN, Nguyen HT, et al. IL-1R signaling enables bystander cells to overcome bacterial blockade of host protein synthesis. Proc Natl Acad Sci USA 2015; 112:7557-7562.
67. Zhu W, Tao L, Quick ML, et al. Sensing cytosolic RpsL by macrophages induces lysosomal cell death and termination of bacterial infection. PLoS Pathog 2015; 11:e1004704.
68. Achkar JM, Casadevall A. Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host Microbe 2013; 13:250-262.
69. Shannon JG, Heinzen RA. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii. Immunol Res 2009; 43 (1-3):138-148.
70. Casadevall A, Pirofski La. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol 2006; 91:1-44.
71. Joller N, Spörri R, Hilbi H, Oxenius A. Induction and protective role of antibodies in Legionella pneumophila infection. Eur J Immunol 2007; 37:3414-3423.
72. Joller N, Weber SS, Mü ller AJ, et al. Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting. Proc Natl Acad Sci USA 2010; 107:20441-20446.
73. Weber SS, Joller N, Küntzel AB, et al. Identification of protective B cell antigens of Legionella pneumophila. J Immunol 2012; 189:841-849.
74. Weber SS, Ducry J, Oxenius A. Dissecting the contributionof IgG subclasses in restricting airway infection with Legionella pneumophila. J Immunol 2014; 193:4053-4059.